MONTREAL, Feb. 29 /CNW Telbec/ - Ranaz Corporation ("Ranaz")
(TSX-V: RNZ), a company specializing in the manufacturing and marketing of
protein and dietary supplements, announces that the TSX Venture Exchange
("TSXV") has conditionally accepted for listing the two series of common share
purchase warrants issued on December 29, 2006 and September 26, 2007.
The warrants issued on December 29, 2006 entitle their holders to
purchase common shares of Ranaz upon payment of $0.60 per share until
December 29, 2008 and the warrants issued on September 26, 2007 entitle their
holders to purchase common shares of Ranaz upon payment of $1.65 per share
until September 26, 2009.
Ranaz expects that the two series of warrants will commence trading on
the TSXV in the middle of March 2008.
About Ranaz Corporation
Ranaz is a corporation specializing in the manufacture and marketing of
protein and dietary supplements. Its mission is to design, develop and market
nutritional, protein and dietary supplements under its own corporate brands,
such as Protidiet and ProtiLife, as well as under private labels.
Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may constitute
forward-looking statements. Such statements, based as they are on the current
expectations of management, inherently involve numerous risks and
uncertainties, known and unknown, many of which are beyond Ranaz's control.
Such risks include but are not limited to: the impact of general economic
conditions, changes in the regulatory environment in the jurisdictions in
which Ranaz does business, stock markets volatility, fluctuations in costs,
and changes to the competitive environment due to consolidation, as well as
other risks disclosed in public filings of Ranaz. Consequently, actual future
results may differ materially from the anticipated results expressed in the
forward-looking statements. The reader should not place undue reliance, if
any, on the forward-looking statements included in this news release. These
statements speak only as of the date made and Ranaz is under no obligation and
disavows any intention to update or revise such statements as a result of any
event, circumstances or otherwise.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.
For further information:
For further information: Martin Vidal, Executive Vice President and
Chief Financial Officer, Ranaz Corporation, (450) 491-7106, ext. 213,
email@example.com; François Kalos, President, SOLAK Communications,
(450) 993-0828, firstname.lastname@example.org